# Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors

> **NCT04064294** · — · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 93 (actual)

## Conditions studied

- Parkinson Disease
- Dyskinesia, Drug-Induced

## Interventions

- **DRUG:** Intravenous Infusion

## Key facts

- **NCT ID:** NCT04064294
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-22
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-03-31
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2025-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04064294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04064294, "Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04064294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*